This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Global Hemoglobin A1c Monitoring Industry

Graph/Chart) II-30

Therapeutic Options for Diabetes II-31

Oral Medication for Type 2 Diabetes II-31

Side Effects of Insulin Therapy II-32

Side Effects II-32

Maintaining A1c Test Result Below 7% II-32

Common Diabetes Management Practices II-32


EKF Obtains CE Mark for Quo-Lab POC HbA1c Analyser II-33

Streck Launches A1c-Cellular Linearity Verification Material II-33

Abbott Obtains CE Marking for ARCHITECT HbA1c (IA) Fully

Automated Assay II-34

Trinity Obtains FDA Approval for Premier Hb9210 HbA1c Device II-34

Siemens Launches Fortified Version of DCA Vantage Analyzer II-35

Tosoh Launches New Assay on its AIA-600II and AIA-360 Analyzers II-35

Siemens Unveils ADVIA® Chemistry HbA1c Assay II-36

Bayer Healthcare Introduces A1CNow® SELFCHECK II-36

Randox Introduces HbA1c Test II-36

Animas Obtains FDA Approval for OneTouch Glucose Management

System II-36

ARKRAY USA Obtains FDA Approval for GLUCOCARD II-37

Bayer's Breeze Blood Glucose Monitoring System Receives

Commendation II-37

Quantimetrix Develops GlycoHemosure II-37

Olympus Life Science Europa Unveils HbA1c assay II-38

Siemens Healthcare Introduces DCA Vantageā„¢ Analyser II-38


Trinity Inks Distribution Agreement with Menarini for Premier

Hb9210 II-39

Danaher Acquires Beckman Coulter II-39

Geonostics Takes Over Consumer Diabetes Tests of FlexSite II-39

EKF Diagnostics Takes Over Quotient Diagnostics II-39

ADA Recommends HbA1c Lab Test for Identification of Pre-Diabetes II-40

HemoCue and MEC Dynamics Inks Distribution Agreement for Avie

A1c POC Test II-40

Trinity Biotech Submits TRIstatā„¢ CLIA Application to FDA II-40

Arkray Partners with Elitech to Supply In-vitro Diagnostic

Systems II-41

Quest Diagnostics Receives Accreditation from NABL and CAP II-41

Quest Diagnostics Achieves Accreditation for its Laboratory in

India II-41

PPD Inks an Agreement with PUL to Expand Lab Services into China II-42

Roche Inks Marketing Agreement with Mankind Pharma II-42

Nicholas Piramal Forms Joint Venture with Arkray II-42

Quotient Diagnostics to Commence Production of Quo-Test System II-42

Pelikan and Eli Lilly Sign Co-Promotion Agreement II-43

4 of 8

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free


Chart of I:DJI
DOW 17,084.49 +33.74 0.20%
S&P 500 2,013.43 +15.91 0.80%
NASDAQ 4,830.47 +19.6820 0.41%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs